Luigi Stasi

Anxiolytic-like effect of the selective Neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze

Fabrizio Bacchi, Aleksander A. Mathé, Luigi Stasi et al. · Peptides · 2006 · 80 citations

Medicine, Neuroscience, Pharmacology +13

Discovery process and pharmacological characterization of a novel dual orexin 1 and orexin 2 receptor antagonist useful for treatment of sleep disorders

Romano Di Fabio, Annalisa Pellacani, Stefania Faedo et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 53 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Effect of a selective OX1R antagonist on food intake and body weight in two strains of rats that differ in susceptibility to dietary-induced obesity

Christy L. White, Yasuyuki Ishii, Tamara Mendoza et al. · Peptides · 2005 · 49 citations

Nursing, Nutritional Sciences, Pharmacology +8

A High-Throughput Screen to Identify LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s Disease Using RapidFire Mass Spectrometry

Melanie Leveridge, Lee Collier, C. Edge et al. · SLAS DISCOVERY · 2015 · 38 citations · Full text

Medicine, Molecular Medicine, Pharmacology +17

Design, Synthesis, and Preliminary Biological Evaluation of Pyrrolo[3,4‐<i>c</i>]quinolin‐1‐one and Oxoisoindoline Derivatives as Aggrecanase Inhibitors

Andrea Cappelli, Chiara Nannicini, Salvatore Valenti et al. · ChemMedChem · 2010 · 32 citations

Pharmacy, Chemistry, Pharmacology +16